[Adiponectin: an anti-carcinogenic adipokine?]

Area of Science:

• Endocrinology
• Oncology
• Metabolic research

Context:

• Adipose tissue, once viewed solely for energy storage, is now recognized as a crucial endocrine organ.
• The discovery of leptin and adiponectin highlights the complex hormonal signaling originating from adipocytes.
• Obesity is linked to hormonal imbalances, including leptin elevation and adiponectin deficiency, impacting cancer risk.

Purpose:

• To review the evidence supporting adiponectin's anti-carcinogenic properties.
• To explore the role of adiponectin in tumor progression, with a focus on breast cancer.
• To discuss how adiponectin deficiency in obesity may influence cancer development.

Summary:

• Adipose tissue secretes hormones (adipokines) that regulate energy balance and have broader physiological effects.
• Adiponectin, a key adipokine, possesses insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties.
• Emerging evidence suggests adiponectin plays a protective role against cancer, including breast cancer, while its deficiency is linked to obesity-related cancers.

Impact:

• Highlights adiponectin as a potential therapeutic target for cancer prevention and treatment.
• Underscores the link between metabolic health, hormonal balance, and cancer risk.
• Provides a foundation for further research into the mechanisms of adiponectin's anti-cancer effects.